Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 290

1.

Associations of Pathogenic Variants in MLH1, MSH2, and MSH6 With Risk of Colorectal Adenomas and Tumors and With Somatic Mutations in Patients With Lynch Syndrome.

Engel C, Ahadova A, Seppälä T, Aretz S, Bigirwamungu-Bargeman M, Bläker H, Bucksch K, Büttner R, de Vos Tot Nederveen Cappel W, Endris V, Holinski-Feder E, Holzapfel S, Hüneburg R, Jacobs MAJM, Koornstra JJ, Langers AM, Lepistö A, Morak M, Möslein G, Peltomäki P, Pylvänäinen K, Rahner N, Renkonen-Sinisalo L, Schulmann K, Steinke-Lange V, Stenzinger A, Strassburg CP, van de Meeberg PC, van Kouwen M, van Leerdam M, Vangala DB, Vecht J, Verhulst ML, von Knebel Doeberitz M, Weitz J, Zachariae S, Loeffler M, Mecklin JP, Kloor M, Vasen HF; German HNPCC Consortium, the Dutch Lynch Syndrome Collaborative Group, and the Finnish Lynch Syndrome Registry.

Gastroenterology. 2020 Jan 8. pii: S0016-5085(20)30014-7. doi: 10.1053/j.gastro.2019.12.032. [Epub ahead of print]

PMID:
31926173
2.

Incident colorectal cancer in Lynch syndrome is usually not preceded by compromised quality of colonoscopy.

Lappalainen J, Holmström D, Lepistö A, Saarnio J, Mecklin JP, Seppälä T.

Scand J Gastroenterol. 2019 Dec;54(12):1473-1480. doi: 10.1080/00365521.2019.1698651. Epub 2019 Dec 12.

PMID:
31829749
3.

Response to Tolva et al.

Sampson JR, Dominguez-Valentin M, Seppälä TT, Møller P.

Genet Med. 2019 Dec 5. doi: 10.1038/s41436-019-0717-5. [Epub ahead of print] No abstract available.

PMID:
31801985
4.

Survival by colon cancer stage and screening interval in Lynch syndrome: a prospective Lynch syndrome database report.

Dominguez-Valentin M, Seppälä TT, Sampson JR, Macrae F, Winship I, Evans DG, Scott RJ, Burn J, Möslein G, Bernstein I, Pylvänäinen K, Renkonen-Sinisalo L, Lepistö A, Lindblom A, Plazzer JP, Tjandra D, Thomas H, Green K, Lalloo F, Crosbie EJ, Hill J, Capella G, Pineda M, Navarro M, Vidal JB, Rønlund K, Nielsen RT, Yilmaz M, Elvang LL, Katz L, Nielsen M, Ten Broeke SW, Nakken S, Hovig E, Sunde L, Kloor M, Knebel Doeberitz MV, Ahadova A, Lindor N, Steinke-Lange V, Holinski-Feder E, Mecklin JP, Møller P.

Hered Cancer Clin Pract. 2019 Oct 14;17:28. doi: 10.1186/s13053-019-0127-3. eCollection 2019.

5.

Retrotransposon insertions can initiate colorectal cancer and are associated with poor survival.

Cajuso T, Sulo P, Tanskanen T, Katainen R, Taira A, Hänninen UA, Kondelin J, Forsström L, Välimäki N, Aavikko M, Kaasinen E, Ristimäki A, Koskensalo S, Lepistö A, Renkonen-Sinisalo L, Seppälä T, Kuopio T, Böhm J, Mecklin JP, Kilpivaara O, Pitkänen E, Palin K, Aaltonen LA.

Nat Commun. 2019 Sep 6;10(1):4022. doi: 10.1038/s41467-019-11770-0.

6.

Factors Affecting Venture Funding of Healthcare AI Companies.

Halminen O, Tenhunen H, Heliste A, Seppälä T.

Stud Health Technol Inform. 2019 Jul 4;262:268-271. doi: 10.3233/SHTI190070.

PMID:
31349319
7.

Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database.

Dominguez-Valentin M, Sampson JR, Seppälä TT, Ten Broeke SW, Plazzer JP, Nakken S, Engel C, Aretz S, Jenkins MA, Sunde L, Bernstein I, Capella G, Balaguer F, Thomas H, Evans DG, Burn J, Greenblatt M, Hovig E, de Vos Tot Nederveen Cappel WH, Sijmons RH, Bertario L, Tibiletti MG, Cavestro GM, Lindblom A, Della Valle A, Lopez-Köstner F, Gluck N, Katz LH, Heinimann K, Vaccaro CA, Büttner R, Görgens H, Holinski-Feder E, Morak M, Holzapfel S, Hüneburg R, Knebel Doeberitz MV, Loeffler M, Rahner N, Schackert HK, Steinke-Lange V, Schmiegel W, Vangala D, Pylvänäinen K, Renkonen-Sinisalo L, Hopper JL, Win AK, Haile RW, Lindor NM, Gallinger S, Le Marchand L, Newcomb PA, Figueiredo JC, Thibodeau SN, Wadt K, Therkildsen C, Okkels H, Ketabi Z, Moreira L, Sánchez A, Serra-Burriel M, Pineda M, Navarro M, Blanco I, Green K, Lalloo F, Crosbie EJ, Hill J, Denton OG, Frayling IM, Rødland EA, Vasen H, Mints M, Neffa F, Esperon P, Alvarez K, Kariv R, Rosner G, Pinero TA, Gonzalez ML, Kalfayan P, Tjandra D, Winship IM, Macrae F, Möslein G, Mecklin JP, Nielsen M, Møller P.

Genet Med. 2020 Jan;22(1):15-25. doi: 10.1038/s41436-019-0596-9. Epub 2019 Jul 24.

PMID:
31337882
8.

Boron neutron capture therapy for locally recurrent head and neck squamous cell carcinoma: An analysis of dose response and survival.

Koivunoro H, Kankaanranta L, Seppälä T, Haapaniemi A, Mäkitie A, Joensuu H.

Radiother Oncol. 2019 Aug;137:153-158. doi: 10.1016/j.radonc.2019.04.033. Epub 2019 May 17.

9.

Exome and immune cell score analyses reveal great variation within synchronous primary colorectal cancers.

Hänninen UA, Wirta EV, Katainen R, Tanskanen T, Hamberg J, Taipale M, Böhm J, Renkonen-Sinisalo L, Lepistö A, Forsström LM, Pitkänen E, Palin K, Seppälä TT, Mäkinen N, Mecklin JP, Aaltonen LA.

Br J Cancer. 2019 Apr;120(9):922-930. doi: 10.1038/s41416-019-0427-4. Epub 2019 Mar 21.

PMID:
30894686
10.

Lack of association between screening interval and cancer stage in Lynch syndrome may be accounted for by over-diagnosis; a prospective Lynch syndrome database report.

Seppälä TT, Ahadova A, Dominguez-Valentin M, Macrae F, Evans DG, Therkildsen C, Sampson J, Scott R, Burn J, Möslein G, Bernstein I, Holinski-Feder E, Pylvänäinen K, Renkonen-Sinisalo L, Lepistö A, Lautrup CK, Lindblom A, Plazzer JP, Winship I, Tjandra D, Katz LH, Aretz S, Hüneburg R, Holzapfel S, Heinimann K, Valle AD, Neffa F, Gluck N, de Vos Tot Nederveen Cappel WH, Vasen H, Morak M, Steinke-Lange V, Engel C, Rahner N, Schmiegel W, Vangala D, Thomas H, Green K, Lalloo F, Crosbie EJ, Hill J, Capella G, Pineda M, Navarro M, Blanco I, Ten Broeke S, Nielsen M, Ljungmann K, Nakken S, Lindor N, Frayling I, Hovig E, Sunde L, Kloor M, Mecklin JP, Kalager M, Møller P.

Hered Cancer Clin Pract. 2019 Feb 28;17:8. doi: 10.1186/s13053-019-0106-8. eCollection 2019.

11.

Combined prognostic value of CD274 (PD-L1)/PDCDI (PD-1) expression and immune cell infiltration in colorectal cancer as per mismatch repair status.

Ahtiainen M, Wirta EV, Kuopio T, Seppälä T, Rantala J, Mecklin JP, Böhm J.

Mod Pathol. 2019 Jun;32(6):866-883. doi: 10.1038/s41379-019-0219-7. Epub 2019 Feb 5.

PMID:
30723299
12.

Epidemiological, clinical and molecular characterization of Lynch-like syndrome: A population-based study.

Porkka N, Lahtinen L, Ahtiainen M, Böhm JP, Kuopio T, Eldfors S, Mecklin JP, Seppälä TT, Peltomäki P.

Int J Cancer. 2019 Jul 1;145(1):87-98. doi: 10.1002/ijc.32085. Epub 2019 Jan 7.

PMID:
30575961
13.

Label-Free Time-Gated Luminescent Detection Method for the Nucleotides with Varying Phosphate Content.

Kopra K, Seppälä T, Rabara D, Abreu-Blanco M, Kulmala S, Holderfield M, Härmä H.

Sensors (Basel). 2018 Nov 16;18(11). pii: E3989. doi: 10.3390/s18113989.

14.

No Difference in Colorectal Cancer Incidence or Stage at Detection by Colonoscopy Among 3 Countries With Different Lynch Syndrome Surveillance Policies.

Engel C, Vasen HF, Seppälä T, Aretz S, Bigirwamungu-Bargeman M, de Boer SY, Bucksch K, Büttner R, Holinski-Feder E, Holzapfel S, Hüneburg R, Jacobs MAJM, Järvinen H, Kloor M, von Knebel Doeberitz M, Koornstra JJ, van Kouwen M, Langers AM, van de Meeberg PC, Morak M, Möslein G, Nagengast FM, Pylvänäinen K, Rahner N, Renkonen-Sinisalo L, Sanduleanu S, Schackert HK, Schmiegel W, Schulmann K, Steinke-Lange V, Strassburg CP, Vecht J, Verhulst ML, de Vos Tot Nederveen Cappel W, Zachariae S, Mecklin JP, Loeffler M; German HNPCC Consortium, the Dutch Lynch Syndrome Collaborative Group, and the Finnish Lynch Syndrome Registry.

Gastroenterology. 2018 Nov;155(5):1400-1409.e2. doi: 10.1053/j.gastro.2018.07.030. Epub 2018 Jul 29.

PMID:
30063918
15.

MRI-only based radiation therapy of prostate cancer: workflow and early clinical experience.

Tenhunen M, Korhonen J, Kapanen M, Seppälä T, Koivula L, Collan J, Saarilahti K, Visapää H.

Acta Oncol. 2018 Jul;57(7):902-907. doi: 10.1080/0284186X.2018.1445284. Epub 2018 Feb 28.

PMID:
29488426
16.

"It Was Not Me That Was Sick, It Was the Building": Rhetorical Identity Management Strategies in the Context of Observed or Suspected Indoor Air Problems in Workplaces.

Finell E, Seppälä T, Suoninen E.

Qual Health Res. 2018 Jul;28(8):1366-1377. doi: 10.1177/1049732317751687. Epub 2018 Feb 14.

PMID:
29441816
17.

Intensity-based dual model method for generation of synthetic CT images from standard T2-weighted MR images - Generalized technique for four different MR scanners.

Koivula L, Kapanen M, Seppälä T, Collan J, Dowling JA, Greer PB, Gustafsson C, Gunnlaugsson A, Olsson LE, Wee L, Korhonen J.

Radiother Oncol. 2017 Dec;125(3):411-419. doi: 10.1016/j.radonc.2017.10.011. Epub 2017 Oct 30.

PMID:
29097012
18.

Colorectal cancer incidence in path_MLH1 carriers subjected to different follow-up protocols: a Prospective Lynch Syndrome Database report.

Seppälä T, Pylvänäinen K, Evans DG, Järvinen H, Renkonen-Sinisalo L, Bernstein I, Holinski-Feder E, Sala P, Lindblom A, Macrae F, Blanco I, Sijmons R, Jeffries J, Vasen H, Burn J, Nakken S, Hovig E, Rødland EA, Tharmaratnam K, de Vos Tot Nederveen Cappel WH, Hill J, Wijnen J, Jenkins M, Genuardi M, Green K, Lalloo F, Sunde L, Mints M, Bertario L, Pineda M, Navarro M, Morak M, Frayling IM, Plazzer JP, Sampson JR, Capella G, Möslein G, Mecklin JP, Møller P; Mallorca Group.

Hered Cancer Clin Pract. 2017 Oct 10;15:18. doi: 10.1186/s13053-017-0078-5. eCollection 2017.

19.

Uptake of genetic testing by the children of Lynch syndrome variant carriers across three generations.

Seppälä TT, Pylvänäinen K, Mecklin JP.

Eur J Hum Genet. 2017 Nov;25(11):1237-1245. doi: 10.1038/ejhg.2017.132. Epub 2017 Aug 23.

20.

Immunoscore in mismatch repair-proficient and -deficient colon cancer.

Wirta EV, Seppälä T, Friman M, Väyrynen J, Ahtiainen M, Kautiainen H, Kuopio T, Kellokumpu I, Mecklin JP, Böhm J.

J Pathol Clin Res. 2017 Jul 19;3(3):203-213. doi: 10.1002/cjp2.71. eCollection 2017 Jul.

21.
22.

Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database.

Møller P, Seppälä TT, Bernstein I, Holinski-Feder E, Sala P, Gareth Evans D, Lindblom A, Macrae F, Blanco I, Sijmons RH, Jeffries J, Vasen HFA, Burn J, Nakken S, Hovig E, Rødland EA, Tharmaratnam K, de Vos Tot Nederveen Cappel WH, Hill J, Wijnen JT, Jenkins MA, Green K, Lalloo F, Sunde L, Mints M, Bertario L, Pineda M, Navarro M, Morak M, Renkonen-Sinisalo L, Valentin MD, Frayling IM, Plazzer JP, Pylvanainen K, Genuardi M, Mecklin JP, Moeslein G, Sampson JR, Capella G; Mallorca Group.

Gut. 2018 Jul;67(7):1306-1316. doi: 10.1136/gutjnl-2017-314057. Epub 2017 Jul 28.

23.

Indoor air problems and experiences of injustice in the workplace: A quantitative and a qualitative study.

Finell E, Seppälä T.

Indoor Air. 2018 Jan;28(1):125-134. doi: 10.1111/ina.12409. Epub 2017 Aug 23.

PMID:
28741743
24.

Subtotal Colectomy for Colon Cancer Reduces the Need for Subsequent Surgery in Lynch Syndrome.

Renkonen-Sinisalo L, Seppälä TT, Järvinen HJ, Mecklin JP.

Dis Colon Rectum. 2017 Aug;60(8):792-799. doi: 10.1097/DCR.0000000000000802.

PMID:
28682964
25.

Correction: Mortality and Length of Stay of Very Low Birth Weight and Very Preterm Infants: A EuroHOPE Study.

Numerato D, Fattore G, Tediosi F, Zanini R, Peltola M, Banks H, Mihalicza P, Lehtonen L, Sveréus S, Heijink R, Klitkou ST, Fletcher E, van der Heijden AA, Lundberg F, Over E, Häkkinen U, Seppälä TT.

PLoS One. 2017 May 1;12(5):e0177040. doi: 10.1371/journal.pone.0177040. eCollection 2017.

26.

Diffusion-weighted magnetic resonance imaging for evaluation of salivary gland function in head and neck cancer patients treated with intensity-modulated radiotherapy.

Loimu V, Seppälä T, Kapanen M, Tuomikoski L, Nurmi H, Mäkitie A, Tenhunen M, Saarilahti K.

Radiother Oncol. 2017 Feb;122(2):178-184. doi: 10.1016/j.radonc.2016.07.008. Epub 2016 Jul 27.

PMID:
27475276
27.

Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome database.

Møller P, Seppälä T, Bernstein I, Holinski-Feder E, Sala P, Evans DG, Lindblom A, Macrae F, Blanco I, Sijmons R, Jeffries J, Vasen H, Burn J, Nakken S, Hovig E, Rødland EA, Tharmaratnam K, de Vos Tot Nederveen Cappel WH, Hill J, Wijnen J, Jenkins M, Green K, Lalloo F, Sunde L, Mints M, Bertario L, Pineda M, Navarro M, Morak M, Renkonen-Sinisalo L, Frayling IM, Plazzer JP, Pylvanainen K, Genuardi M, Mecklin JP, Möslein G, Sampson JR, Capella G; Mallorca Group (http://mallorca-group.org).

Gut. 2017 Sep;66(9):1657-1664. doi: 10.1136/gutjnl-2016-311403. Epub 2016 Jun 3.

28.

[Diagnosis and treatment of Lynch syndrome].

Seppälä T, Pylvänäinen K, Renkonen-Sinisalo L, Böhm J, Kuopio T, Järvinen HJ, Mecklin JP.

Duodecim. 2016;132(3):233-40. Review. Finnish.

PMID:
26951027
29.

Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database.

Møller P, Seppälä T, Bernstein I, Holinski-Feder E, Sala P, Evans DG, Lindblom A, Macrae F, Blanco I, Sijmons R, Jeffries J, Vasen H, Burn J, Nakken S, Hovig E, Rødland EA, Tharmaratnam K, de Vos Tot Nederveen Cappel WH, Hill J, Wijnen J, Green K, Lalloo F, Sunde L, Mints M, Bertario L, Pineda M, Navarro M, Morak M, Renkonen-Sinisalo L, Frayling IM, Plazzer JP, Pylvanainen K, Sampson JR, Capella G, Mecklin JP, Möslein G; Mallorca Group (http://mallorca-group.eu).

Gut. 2017 Mar;66(3):464-472. doi: 10.1136/gutjnl-2015-309675. Epub 2015 Dec 9.

30.

Outcome, Use of Resources and Their Relationship in the Treatment of AMI, Stroke and Hip Fracture at European Hospitals.

Häkkinen U, Rosenqvist G, Iversen T, Rehnberg C, Seppälä TT; EuroHOPE study group.

Health Econ. 2015 Dec;24 Suppl 2:116-39. doi: 10.1002/hec.3270.

PMID:
26633872
31.

Individual and Regional-level Factors Contributing to Variation in Length of Stay After Cerebral Infarction in Six European Countries.

Peltola M, Seppälä TT, Malmivaara A, Belicza É, Numerato D, Goude F, Fletcher E, Heijink R; EuroHOPE study group.

Health Econ. 2015 Dec;24 Suppl 2:38-52. doi: 10.1002/hec.3264.

PMID:
26633867
32.

Towards Explaining International Differences in Health Care Performance: Results of the EuroHOPE Project.

Häkkinen U, Iversen T, Peltola M, Rehnberg C, Seppälä TT; EuroHOPE study group.

Health Econ. 2015 Dec;24 Suppl 2:1-4. doi: 10.1002/hec.3282. No abstract available.

PMID:
26633864
33.

Biokinetic analysis of tissue boron (¹⁰B) concentrations of glioma patients treated with BNCT in Finland.

Koivunoro H, Hippeläinen E, Auterinen I, Kankaanranta L, Kulvik M, Laakso J, Seppälä T, Savolainen S, Joensuu H.

Appl Radiat Isot. 2015 Dec;106:189-94. doi: 10.1016/j.apradiso.2015.08.014. Epub 2015 Aug 14.

PMID:
26363564
34.

Treatment provided in the Public Dental Service in Finland in 2009.

Widström E, Linden J, Tiira H, Seppälä TT, Ekqvist M.

Community Dent Health. 2015 Mar;32(1):60-4.

PMID:
26263595
35.

Toward a more patient-specific model of post-radiotherapy saliva secretion for head and neck cancer patients.

Tuomikoski L, Kapanen M, Collan J, Keyriläinen J, Saarilahti K, Loimu V, Seppälä T, Tenhunen M.

Acta Oncol. 2015;54(9):1310-6. doi: 10.3109/0284186X.2015.1067717. Epub 2015 Aug 27.

PMID:
26203929
36.

Converting from CT- to MRI-only-based target definition in radiotherapy of localized prostate cancer: A comparison between two modalities.

Seppälä T, Visapää H, Collan J, Kapanen M, Beule A, Kouri M, Tenhunen M, Saarilahti K.

Strahlenther Onkol. 2015 Nov;191(11):862-8. doi: 10.1007/s00066-015-0868-5. Epub 2015 Jul 14.

PMID:
26168782
37.

Mortality and Length of Stay of Very Low Birth Weight and Very Preterm Infants: A EuroHOPE Study.

Numerato D, Fattore G, Tediosi F, Zanini R, Peltola M, Banks H, Mihalicza P, Lehtonen L, Sveréus S, Heijink R, Klitkou ST, Fletcher E, Heijden Av, Lundberg F, Over E, Häkkinen U, Seppälä TT.

PLoS One. 2015 Jun 29;10(6):e0131685. doi: 10.1371/journal.pone.0131685. eCollection 2015. Erratum in: PLoS One. 2017 May 1;12 (5):e0177040.

38.

Combination of microsatellite instability and BRAF mutation status for subtyping colorectal cancer.

Seppälä TT, Böhm JP, Friman M, Lahtinen L, Väyrynen VM, Liipo TK, Ristimäki AP, Kairaluoma MV, Kellokumpu IH, Kuopio TH, Mecklin JP.

Br J Cancer. 2015 Jun 9;112(12):1966-75. doi: 10.1038/bjc.2015.160. Epub 2015 May 14.

39.

De Garengeot's hernia: 40 years after Bassini inguinal hernioplasty.

Liipo TK, Seppälä TT, Mattila AK.

BMJ Case Rep. 2015 Mar 2;2015. pii: bcr2014208327. doi: 10.1136/bcr-2014-208327.

40.

Amyloid-β and Tau Dynamics in Human Brain Interstitial Fluid in Patients with Suspected Normal Pressure Hydrocephalus.

Herukka SK, Rummukainen J, Ihalainen J, von Und Zu Fraunberg M, Koivisto AM, Nerg O, Puli LK, Seppälä TT, Zetterberg H, Pyykkö OT, Helisalmi S, Tanila H, Alafuzoff I, Hiltunen M, Rinne J, Soininen H, Jääskeläinen JE, Leinonen V.

J Alzheimers Dis. 2015;46(1):261-9. doi: 10.3233/JAD-142862.

PMID:
25720406
41.

Coexisting ipsilateral right femoral hernia and incarcerated obturator hernia.

Seppälä TT, Tuuliranta M.

BMJ Case Rep. 2015 Feb 25;2015. pii: bcr2014208361. doi: 10.1136/bcr-2014-208361.

42.

Feasibility of MRI-based reference images for image-guided radiotherapy of the pelvis with either cone-beam computed tomography or planar localization images.

Korhonen J, Kapanen M, Sonke JJ, Wee L, Salli E, Keyriläinen J, Seppälä T, Tenhunen M.

Acta Oncol. 2015 Jun;54(6):889-95. doi: 10.3109/0284186X.2014.958197. Epub 2014 Sep 18.

PMID:
25233439
43.

Comparing ischaemic stroke in six European countries. The EuroHOPE register study.

Malmivaara A, Meretoja A, Peltola M, Numerato D, Heijink R, Engelfriet P, Wild SH, Belicza É, Bereczki D, Medin E, Goude F, Boncoraglio G, Tatlisumak T, Seppälä T, Häkkinen U.

Eur J Neurol. 2015 Feb;22(2):284-91, e25-6. doi: 10.1111/ene.12560. Epub 2014 Sep 8.

PMID:
25196190
44.

Influence of MRI-based bone outline definition errors on external radiotherapy dose calculation accuracy in heterogeneous pseudo-CT images of prostate cancer patients.

Korhonen J, Kapanen M, Keyriläinen J, Seppälä T, Tuomikoski L, Tenhunen M.

Acta Oncol. 2014 Aug;53(8):1100-6. doi: 10.3109/0284186X.2014.929737. Epub 2014 Jul 7.

PMID:
24998163
45.

Cerebrospinal fluid biomarker and brain biopsy findings in idiopathic normal pressure hydrocephalus.

Pyykkö OT, Lumela M, Rummukainen J, Nerg O, Seppälä TT, Herukka SK, Koivisto AM, Alafuzoff I, Puli L, Savolainen S, Soininen H, Jääskeläinen JE, Hiltunen M, Zetterberg H, Leinonen V.

PLoS One. 2014 Mar 17;9(3):e91974. doi: 10.1371/journal.pone.0091974. eCollection 2014.

46.

A dual model HU conversion from MRI intensity values within and outside of bone segment for MRI-based radiotherapy treatment planning of prostate cancer.

Korhonen J, Kapanen M, Keyriläinen J, Seppälä T, Tenhunen M.

Med Phys. 2014 Jan;41(1):011704. doi: 10.1118/1.4842575.

PMID:
24387496
47.

[Early diagnosis of Alzheimer's disease].

Seppälä T, Herukka SK, Remes AM.

Duodecim. 2013;129(19):2003-10. Review. Finnish.

PMID:
24218731
48.

Weight change and health related quality of life: population-based longitudinal study of the effects of health related quality of life on the success of weight management.

Seppälä T, Mäntyselkä P, Saxen U, Kautiainen H, Järvenpää S, Korhonen PE.

J Community Health. 2014 Apr;39(2):349-54. doi: 10.1007/s10900-013-9768-8.

PMID:
24046214
49.

Antibiotic prophylaxis for hysterectomy, a prospective cohort study: cefuroxime, metronidazole, or both?

Brummer TH, Heikkinen AM, Jalkanen J, Fraser J, Mäkinen J, Tomás E, Seppälä T, Sjöberg J, Härkki P.

BJOG. 2013 Sep;120(10):1269-76. doi: 10.1111/1471-0528.12178. Epub 2013 Jun 21.

50.

Body mass index and health-related quality of life in apparently healthy individuals.

Korhonen PE, Seppälä T, Järvenpää S, Kautiainen H.

Qual Life Res. 2014 Feb;23(1):67-74. doi: 10.1007/s11136-013-0433-6. Epub 2013 May 19.

PMID:
23686578

Supplemental Content

Loading ...
Support Center